Risky Haplotype for Treatment-Related Premature Menopause Proposed in Pediatric Cancer Survivors
A St. Jude Children's Research Hospital-led team has identified a haplotype that appears to coincide with the risk of premature menopause in pediatric cancer survivors treated with gonadotoxic drugs.